MINI FUTURE LONG - VIRBAC | Real-time Euronext Paris 06:43:19 2024-05-21 am EDT | ||
| 0.605 EUR | +8.04% |
|
| Current month | +3.70% | ||
| 1 month | -31.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
VIRBAC
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 0.605 | +8.04% |
| 24-05-20 | 0.56 | -8.20% |
| 24-05-17 | 0.61 | -7.58% |
| 24-05-16 | 0.66 | -10.81% |
| 24-05-15 | 0.74 | +1.37% |
Real-time Euronext Paris
Last update May 21, 2024 at 06:43 am EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | VIRBAC |
| Issuer | 
BNP Paribas
|
| 8HEOB | |
| ISIN | FRBNPP06MS59 |
| Date issued | 2024-03-26 |
| Strike | 297.9 € |
| Maturity | Unlimited |
| Parity | 100 : 1 |
| Emission price | 0.57 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.835 € |
|---|---|
| Lowest since issue | 0.435 € |
| Spread | 0.01 € |
| Spread % | 1.64% |
Company Profile
Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families:
- pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips;
- livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc.
Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
Consensus: Virbac
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
350
EUR
Average target price
372.4
EUR
Spread / Average Target
+6.41%
- Stock Market
- Certificates
- 8HEOB Certificat